Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
Titel:
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
Auteur:
Walker, Alison R. Komrokji, Rami S. Ifthikharuddin, Jainulabdeen Messina, Patti Mulford, Deborah Becker, Michael Friedberg, Jonathan Oliva, Jamie Phillips, Gordon Liesveld, Jane L. Abboud, Camille